Melt&Marble
PrivateLast Round
Series A
Dec 8, 2025
Total Funding Raised
$26.22M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Melt&Marble operates in Healthcare & Life Sciences and is based in Gothenburg. Its latest recorded funding round was a Series A round in December 2025.
Melt&Marble is a biotechnology company that produces sustainable, animal-free designer fats using precision fermentation for applications in plant-based foods and personal care products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melt&Marble Comparables
Compare Melt&Marble with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yali Bio | 91% | |
| Nourish Ingredients | 85% | |
| Clean Food Group | 85% |
For institutional investors. Book with your work email.
Melt&Marble Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 8, 2025 | ||||
| Grant | Jul 29, 2024 | ||||
| Series A | Dec 8, 2023 | ||||
| Seed | May 5, 2022 | ||||
| Seed | Aug 20, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Melt&Marble Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A |
| Be8 Ventures | Seed |
| Catalyze Capital | Series A |
| Good Startup | Seed |
| European Commission | Grant |
| Purple Orange Ventures | Seed |
| Nordic Foodtech VC | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
$8.6M Series A round completed.
- Dec 8, 2025
Launching precision-fermented 'designer fats' for food and personal care.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 4, 2026
Melt&Marble AB develops designer fats and lipids for food and personal care using microbial engineering and precision fermentation, including Marble7, its first precision-fermented lipid ingredient for personal care, in Sweden on Aug 4th '26.
For institutional investors. Book with your work email.
Melt&Marble Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Melt&Marble's valuation, stock price, and market status.
Is Melt&Marble a public or private company?
Melt&Marble is a private company.
What is the current stock price of Melt&Marble?
Melt&Marble is a private company, so its shares have no public market price. Caplight tracks Melt&Marble's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Melt&Marble worth (valuation)?
Valuation information for Melt&Marble is not publicly available.
Can I buy Melt&Marble stock?
Melt&Marble shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Melt&Marble's last funding round?
Melt&Marble's most recent funding round was Series A on December 8, 2025.
Who are the main investors in Melt&Marble?
Key investors in Melt&Marble include Nordic Foodtech VC, Industrifonden, Lever VC, Nordic Foodtech VC.
Will Melt&Marble IPO soon?
No public IPO plans have been announced for Melt&Marble.
How can I track Melt&Marble secondary market activity?
Caplight tracks bids, offers, and trades in Melt&Marble's shares on secondary markets.